Involving Patients in Decision Making Improves Multiple Sclerosis Treatment

Clinicians should take time to listen to the patient and learn about their values and preferences for the treatment to be effective.

Shared decision-making between patients and their doctors and nurses is one of the cornerstones of multiple sclerosis treatment, according to a report in the journal Practical Neurology.

"Patients with MS are often very interested //and involved in their own disease management and therefore should be empowered to play an active role in their care," wrote author Amy Perrin Ross, APN, MSN, CNRN, MSCN.

Multiple sclerosis - Symptoms - Causes - Diagnosis - Treatment
Multiple sclerosis can be a severely disabling autoimmune disease that affects the myelin or insulating layer of the nerve fibers and typically has remissions and relapses

‘The more patients with multiple sclerosis are involved in shared decision-making, the more likely they will be adherent to the therapy and lifestyle recommendations.’

"Shared decision-making is therefore essential to optimal treatment and quality of life for patients with MS."

Ms. Perrin Ross, a board-certified neuroscience nurse, is neuroscience program coordinator at Loyola University Medical Center and a member of the board of directors of the Consortium of Multiple Sclerosis Centers.

In shared decision-making, the clinician and patient work together to make decisions and select tests, treatments and care plans. The process encompasses evidence-based treatments as well as lifestyle and environmental factors.

Multiple Sclerosis – Treatment to Reduce Symptoms and Modify course of Disease
Multiple sclerosis is treated with drugs that modify the course of the disease, suppress immunity and relieve symptoms.

The clinician educates the patient about the disease and makes recommendations based on risk factors, genetic factors, potential triggers and other elements.

"After reviewing and educating patients about the available options, clinicians should take time to listen to the patient and learn about their values and preferences, as these should be taken into account during consideration of optimal treatment," Ms. Perrin Ross wrote.

Breakthrough in Research as Multiple Sclerosis-causing Key Protein Identified
Protein Rab 32 found by scientists to play an important role in the development of multiple sclerosis.

The five steps of shared decision-making are:

Engage patient participation
Explore and compare treatment options
Assess patient values and preferences
Reach a decision on treatment with the patient
Evaluate the patient decision

A comprehensive team approach, like the one used at Loyola Medicine, often is needed to ensure patients are well informed about effective treatments and a healthy lifestyle.

The team can include a neurologist, nurse, physician assistant, primary care provider, physical therapist, occupational therapist, speech therapist, podiatrist, psychiatrist, urologist, nutritionist and pharmacist. A nurse coordinator or nurse case manager can help coordinate care and guide patients through the process.

Multiple Sclerosis : Possible Treatment Target Identified
The role of protein Rab32 in the impairment of mitochondrial dynamics and cell survival in multiple sclerosis has been identified.

Shared decision-making can be time consuming, especially in the beginning. But the more patients feel they are supported, "the more comfortable they are to manage their own disease and feel empowered to make decisions about their care and their lives," Ms. Perrin Ross wrote.

Source-Eurekalert